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Abstract
Background: Stigma, discrimination, lack of privacy, and long waiting times partly explain why six out of ten individuals
living with HIV do not access facility-based testing. By circumventing these barriers, self-testing offers potential for more
people to know their sero-status. Recent approval of an in-home HIV self test in the US has sparked self-testing initiatives,
yet data on acceptability, feasibility, and linkages to care are limited. We systematically reviewed evidence on supervised
(self-testing and counselling aided by a health care professional) and unsupervised (performed by self-tester with access to
phone/internet counselling) self-testing strategies.
Methods and Findings: Seven databases (Medline [via PubMed], Biosis, PsycINFO, Cinahl, African Medicus, LILACS, and
EMBASE) and conference abstracts of six major HIV/sexually transmitted infections conferences were searched from 1st
January 2000–30th October 2012. 1,221 citations were identified and 21 studies included for review. Seven studies
evaluated an unsupervised strategy and 14 evaluated a supervised strategy. For both strategies, data on acceptability
(range: 74%–96%), preference (range: 61%–91%), and partner self-testing (range: 80%–97%) were high. A high specificity
(range: 99.8%–100%) was observed for both strategies, while a lower sensitivity was reported in the unsupervised (range:
92.9%–100%; one study) versus supervised (range: 97.4%–97.9%; three studies) strategy. Regarding feasibility of linkage to
counselling and care, 96% (n= 102/106) of individuals testing positive for HIV stated they would seek post-test counselling
(unsupervised strategy, one study). No extreme adverse events were noted. The majority of data (n= 11,019/12,402
individuals, 89%) were from high-income settings and 71% (n= 15/21) of studies were cross-sectional in design, thus
limiting our analysis.
Conclusions: Both supervised and unsupervised testing strategies were highly acceptable, preferred, and more likely to
result in partner self-testing. However, no studies evaluated post-test linkage with counselling and treatment outcomes and
reporting quality was poor. Thus, controlled trials of high quality from diverse settings are warranted to confirm and extend
these findings.
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Introduction
On July 3, 2012 the US Food and Drug Administration (FDA)
approved an oral point-of-care (POC) HIV self test, OraQuick, for
over-the-counter (OTC) sale on the basis of a positive recommen-
dation from their Blood Product Advisory Committee (FDA-
BPAC) [1]. This decision, the first for a self test for an infectious
disease, is an important step towards normalizing the process of
receiving an HIV diagnosis, currently beset with stigma and
discrimination. The FDA approved the oral HIV test even though
it is less sensitive than a blood test because of its potential to allow
more people to know their sero-status and thus potentially avert
thousands of cases of HIV transmission. Although this approval
has paved the way for a self-testing paradigm complementary to
facility-based testing, evidence is needed to understand whether
self-testing will lead to more people knowing their HIV status and
whether self-testing can be implemented, and operationalized as a
strategy in global settings.
If HIV self-testing is to realize its promise of increasing the
number of at-risk individuals knowing their sero-status evidence is
needed to demonstrate that self-testing strategies can be an
acceptable or preferred mode of HIV testing. Crucially, it is
important to demonstrate that individuals who are self-testing can
be given reasonable assurance of test accuracy, especially for
populations with varying backgrounds and literacy levels.
Furthermore, evidence on whether self-testing will offer a private,
confidential alternative to facility-based HIV testing with a safe
conduit to care and treatment is needed to improve outcomes for
both individuals and at-risk populations.
If self-testing is proven to help increase knowledge of sero-status
in those individuals that do not seek facility-based testing and
improves linkages to care and treatment rates in the community,
then it will stand to impact control HIV at the population level.
However, as of 2013, that vision remains unrealized. Facility-
based HIV testing strategies (voluntary testing and counselling,
provider-initiated and conventional client-initiated testing and
counselling) have been in place for decades [2]. However, stigma
and discrimination faced in these settings remain key barriers to
testing [3]. Additional barriers include fear of visibility, fear of lack
of confidentiality of a positive test result, a lack of privacy, and
increased waiting time to obtain a test result [4]. It is no surprise
therefore that about six in ten individuals living with HIV infection
remain untested globally and as a consequence, are unaware of
their HIV sero-status [5].
In this context, self-testing offers some promise in alleviating or
eliminating these barriers. It provides individuals with the option
of knowing their HIV status in the privacy of their homes and
therefore has the potential to negate the effects of stigma, and
reduce perceived discrimination. Although self-testing has the
potential to help increase the numbers of individuals aware of their
HIV sero-status, this strategy has been beset with concerns and
challenges about its success [6–8]. This is also partly attributed to a
lack of evidence on self-testing behaviors, and effective linkage
initiation to treatment and counselling after self-testing. To our
knowledge, only one published narrative review has evaluated the
potential role of self-testing in health care worker populations [2].
A related meta-analysis compared the diagnostic accuracy of oral
versus finger-stick antibody POC tests to demonstrate that oral
POC tests could play a role in future self-testing initiatives [9].
Another systematic review on home-based rapid testing initiatives
where people are encouraged to get tested and counselled by
health care workers in home visits (thus different from self-testing)
alluded to the potential of offering self-testing to individuals in
resource constrained settings [10]. With a view to fill a knowledge
gap in understanding supervised and unsupervised self-testing
strategies that are being evaluated globally, and to guide their
effective implementation in high-income and resource constrained
settings, we performed a systematic review.
Methods
We systematically reviewed the literature to evaluate the current
evidence on two common strategies: (a) supervised and (b)
unsupervised self-testing strategies in high- and low-risk popula-
tions worldwide. A supervised strategy (self-testing and counselling
processes) was always aided by a health care professional (HCP).
An unsupervised strategy was performed by a self-tester without
any help, but with counselling and linkage to care offered off-site
(e.g., over the phone) by a HCP. Our specific objectives included
documentation of all outcomes from implementation research
associated with self-testing and counselling strategies (acceptability,
accuracy, feasibility, cost, and counselling preferences). Further,
data on challenges, concerns, and barriers documented from
qualitative research or mixed methods studies were also synthe-
sized.
This review was reported following PRISMA guidelines.
Search Strategy and Identification of Studies
For the period of January 1, 2000–October 30, 2012, we
searched seven electronic databases (Medline [via PubMed],
Biosis, PsycINFO, Cinahl, African Medicus, LILACS, and
EMBASE) and abstracts from six major HIV/sexually transmitted
infections (STIs) conferences (Canadian Association of HIV
Research [CAHR], International Society for Sexually Transmitted
Diseases Research [ISSTDR], International AIDS Society [IAS],
Conference on Retroviruses and Opportunistic Infections
[CROI], Infectious Diseases Society of America [IDSA], and the
Inter Science Conference on Antimicrobial Agents and Chemo-
therapy [ICAAC]). Additionally, we reviewed bibliographies and
contacted the authors for original data. We included abstracts if
full-texts were not available.
Our search string (limited to humans) was: (1) ‘‘HIV’’[MeSH]
OR ‘‘HIV Seropositivity’’[MeSH] OR ‘‘HIV Infections’’[MeSH]
AND (2) (‘‘Self Care’’[MeSH]) OR ‘‘Self Administration’’[MeSH])
OR ‘‘Point-of-Care Systems’’[MeSH] OR ‘‘self*test*’’ OR
‘‘rapid*test*.’’
Study Selection
Two reviewers (JS and SS) independently screened all citations.
Please refer to the flow chart for details (Figure 1).
Eligibility Criteria
Full-text articles, brief reports, or abstracts that evaluated HIV
self-testing strategies in any part of the world were included.
Reviews, perspectives, editorials, and studies that did not evaluate
self-testing strategies (home-based non self test) were excluded
(Figure 1).
Data Abstraction
Two reviewers independently abstracted data from quantitative
(JS and SS) and qualitative (SP and JS) studies. Concordance
between reviewers was high at 90%. Disagreements were resolved
by consultation with a third reviewer (NPP). A pre-piloted data
abstraction form was used. Variables such as study characteristics,
populations, study design, type of strategy, and outcomes were
tabulated (Tables 2–4).
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Quality Assessment and Data Synthesis
A quality critique of quantitative data from cross-sectional
(Tables S1 and S2) and cohort studies (Table S3) was performed
using the STROBE reporting checklist [11]. Two articles,
although not peer reviewed, were critiqued using the STROBE
checklist as they were reporting outcomes of cohort and cross-
sectional studies [12,13]. Similarly, a conference abstract reporting
a RCT (Table S4) was appraised using the CONSORT guidelines
[14]. A guide [15] for critically appraising qualitative research was
used to appraise qualitative studies [12,16–19]. The only study
that could not be quality critiqued was an announcement of an
implementation strategy through a conference abstract [20]. Due
to lack of standardized reporting of primary and secondary
outcomes, a meta-analysis was not conducted.
Results
A total of 1,207 studies were identified from databases and
bibliography searches and 14 abstracts retrieved from conferences
for a total of 1,221 citations (please refer to Figure 1). After
removing duplicates, 1,108 citations were reviewed in the first
screen (Figure 1). Of 40 articles that were reviewed in the second
screen, 20 were included. Reasons for exclusion of the remaining
20 studies were: repeat of reporting in abstract and full-text (n= 4),
Figure 1. Flow chart of study search and selection.
doi:10.1371/journal.pmed.1001414.g001
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narrative review (n= 1), and topic irrelevant to this review (n= 15).
One article reported on two separate studies, thus, a total of 21
studies were synthesized. Table 1 provides a list of definitions for
the key outcomes or characteristics documented in this review.
Table 2 presents the description of the 21 included studies, and
Tables S1 to S4 present their detailed STROBE and CONSORT
quality reporting assessment, where applicable.
Description of Included Studies
Of the 21 studies included, 16 (n= 16/21, 76%) were conducted
in high-income [13,16,20–32] versus five (n= 5/21, 24%) in
resource constrained country settings [12,17–19,33]. Total sample
size varied from 27 to 5,798. Two main strategies for HIV self-
testing were identified, supervised and unsupervised, and the
studies classification is illustrated in Figure 2. The total sample size
for the supervised testing strategy was 4,890 individuals and 7,512
for the unsupervised testing strategy. Our review provides data
from 1,383 participants in resource constrained settings, compared
to 11,019 in high-income settings, thus the bulk of data (89%) was
from high-income settings. Study populations varied from high at-
risk for HIV to low-risk general populations.
A vast majority of studies evaluated oral self tests (n= 14/21,
67%), while others used finger-stick-based tests. The two self-
testing strategies, unsupervised and supervised, were evaluated
with two oral POC tests, OraQuick and Calypte
[12,13,16,17,20,22,24,26–28,29,32,33]. With the exception of
one completed randomized controlled trial (RCT) [25], all other
studies (n= 20/21, 95%) were observational, of which 14 (n= 14/
20, 70%) were cross-sectional or cohort studies [12,13,16,21–
24,26–29,32,33], while five (n= 5/20, 25%) were surveys [17–
19,30,31], and one reported a study in progress that evaluated an
unsupervised testing strategy coupled with Internet counselling for
high-risk populations in the Netherlands [20].
A supervised self-testing strategy was evaluated in 14 (n= 14/21,
67%) studies, in both high- and low-risk populations with varying
level of education, and access to resources. Although study
participants performed the self test themselves, a HCP assisted the
self-tester in any aspect of self-testing and counselling, if called
upon. This assistance varied across studies, e.g., understanding the
conduct of self-testing, helping with result interpretation, counsel-
ling, and initiating linkages for confirmatory testing.
In the unsupervised self-testing strategy (n= 7/21 studies, 33%),
no assistance was offered by HCPs in the conduct and
interpretation of self tests, but counselling was available off-site
(on the phone or over the Internet). Unsupervised self-testing was
evaluated primarily among urban and educated populations in
high-income and resource constrained settings, such as a proposed
evaluation in the Netherlands [20], HCPs in Kenya [12], urban
men who have sex with men (MSM) in the US [25], general
literate populations in the US [13], general population at unknown
risk of HIV [26], urban non-monogamous MSM in the US [22],
and attendees of a rapid HIV testing site in Spain [23].
Quantitative Data
Table 1 provides the definitions used for reporting outcomes,
facilitating their interpretation, documentation, and synthesis
stratified by strategies.
Acceptability
For both supervised and unsupervised self-testing strategies,
acceptability (Table 3) was high (range: 74%–96%). For supervised
strategies, acceptability was documented in seven studies. Accept-
ability varied from 74% (n= 42/57) in MSM in the US [16], to
78% (n= 208/267) in clinic attendees from Spain [21], to 85%
(n= 478/564) in clinic attendees from the US [24], to 92%
(n= 198/216 and n= 206/283) from household participants in
Malawi [18,33], to 95% (n= 100/105) in educated student
populations in Canada [29], but was much lower (n= 85/354,
24%) in an early 2001 study in the US [30]. It should be noted that
acceptability was measured in a research context, where partic-
ipants voluntarily show up for self-testing. For unsupervised
strategies, acceptability was documented in two studies, and
ranged from 78% (n= 230/295) in HCPs in Kenya [12] to 84%
(n= 27/32) in non-monogamous urban MSM in the US [22].
Accuracy
Accuracy of self tests was reported by sensitivity and specificity
parameters with the index self test being compared to the reference
standard prevalent in each research setting. In high-resource country
settings, the reference standard algorithm used was dual ELISA and
Western blot performed on blood samples. In resource constrained
settings, the three rapid test algorithm was employed.
Table 1. Definition of outcomes.
Outcome Definition
Acceptability Numerator defined as those individuals who chose to self-test.
Denominator defined as all those who were offered and consented to test.
Uptake = numerator/denominator (computed as a percentage)
Accuracy Accuracy was defined by sensitivity and specificity parameters.
Index test was a self-test result.
Reference standard tests were combination of conventional lab tests for HIV (rapid tests
or ELISA with p24 and/or Western blot depending on high- versus low-resource setting)
Concordance Concordance for self-testing was reported as a measure of agreement between the test
result between the individual and health care worker quantified either as percentage
agreement or with the Cohen’s Kappa (k) inter-rater agreement
Feasibility Documented completion of self-testing and counselling process.
Includes ease of performance and interpretation of self-testing results, and
documentation of errors, initiation of linkages.
Motivators Factors contributing to the acceptability of HIV self tests
doi:10.1371/journal.pmed.1001414.t001
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Across both strategies, irrespective of the reference standard
used, the specificity of the HIV self tests was consistently
documented to be high, but sensitivity estimates varied greatly.
In the supervised testing strategy, high overall accuracy was
generally observed. For example, a high sensitivity (97.9%; 95%
CI 87.9–100) and a high specificity (100%; 95% CI 97.8–100) was
reported in Malawi [33], as well as in a US-based study (sensitivity
97.9%; 95% CI 95.0–99.4—specificity 99.8%; 95% CI 98.1–100)
[13], and in a Singapore-based study (sensitivity 97.4%; 95% CI
95.1–99.7—specificity 99.9%; 95% CI 99.6–100) [28]. However,
Table 3. Study outcomes: acceptability, accuracy, agreement and cost preference.
Test
Strategy Author Year Study Setting Acceptability Accuracy
Agreement or
Concordance
Cost Preference
and WTP (US$)
Test strategy: supervised
Skolnik 2001 [30] USA 24% NA NA NA
Spielberg 2003 (a)
[32]
USA NA NA Oral fluid test:
95%, blood-based
test: 89%
70% WTP#US$15;
40% WTP US$20
Spielberg 2003 (b)
[31]
USA NA NA NA WTP US$10–
US$15
Lee 2007 [27] Singapore NA NA k value = 0.28
(p,0.01)
88% WTP US$7–
US$13
Spielberg 2007 [19] India NA NA NA NA
Gaydos 2011 [24] USA 85% NA 99.6% NA
Carballo-Dieguez
2012 (a) [16]
USA 74% NA NA NA
Pant Pai 2012 [29] Canada 95% NA 100% Max WTP 20US$
OraSure 2012
(phase IIb) [13]
USA NA Sensitivity: 97.9% (95% CI 95.0–99.4);
specificity: 99.79% (95% CI 98.1–100)
NA NA
Belza 2012 [21] Spain 78% 1% invalid 99% (95% CI
96.6–99.9)
NA
Ng 2012 [28] Singapore NA Sensitivity: 97.4% (95% CI 95.1–99.7)
Specificity: 99.9%(95% CI 99.6–100) 0.5%
invalid
k value = 0.97
(95% CI 0.95–0.99)
28% WTP.US$15
Chavula 2011 [17] Malawi NA NA NA NA
Choko 2011 [33] Malawi 92% Sensitivity: 97.9% (95% CI 87.9–100)
Specificity: 100% (95% CI 97.8–100)
NA NA
MacPherson 2011
[18]
Malawi 92% NA NA NA
Test strategy: unsupervised
Kalibala 2011 [12] Kenya 78% NA NA NA
Katz 2012 [25] USA NA NA NA 45% WTP#US$20;
25% WTP US$20–
US$40, 17%
WTP$US$40, 13%
WTP free
OraSure 2012
(phase III) [13]
USA NA High-prevalence setting: Sensitivity:
92.9% (95% CI 86.5–96.89); Specificity:
99.98% (95% CI 99.87–100); PPV: 99.1%
(95% CI 94.86–99.98); NPV: 99.81%
(95% CI 99.63–99.92) Low-prevalence
setting: Sensitivity: 100% (95% CI NA;
0 FN); Specificity: 100% (95% CI 99.66–100);
PPV: 100% (95% CI 2.5–100); NPV: 100%
(95% CI 99.66–100)
NA NA
Fuente 2012 [23] Spain NA 8% (95% CI 4.8–11.2) invalid tests NA 18% WTP.US$38,
22% WTP US$25–
US$38, 5.2% WTP
free
Lee 2012 [26] USA NA Specificity: 99.8% (95% CI 98.1–100),
1.8% testing error
NA NA
Carballo-Dieguez
2012 (b) [22]
USA 84% NA NA NA
Helm 2012 [20] Netherlands NA NA NA NA
FN, false negative; K, kappa statistic; NA, not available; NPV, negative predictive value; PPV, positive predictive value; WTP, willingness to pay.
doi:10.1371/journal.pmed.1001414.t003
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Table 4. Study outcomes: counselling preference, feasibility, linkages, errors, motivation, label comprehension, and test
preference.
Test
Strategy Author Year
Study
Setting Counselling Preference
Feasibility, Linkages,
Errors
Motivation, Label
Comprehension Test Preference
Supervised self-testing strategies
Skolnik 2001
[30]
USA 100% for in-person pre and
post test
NA Convenience, speed,
privacy, and anonymity
NA
Spielberg 2003
(a) [32]
USA NA Errors noted in placing
test device in developer
solution
NA 61% preferred
testing at home
Spielberg 2003
(b) [31]
USA NA NA NA 20% prefer home
self-testing versus
conventional test
Lee 2007 [27] Singapore 79% for post-test counselling NA Convenience, speed,
privacy, and anonymity
NA
Spielberg 2007
[19]
India Computer-based pre and
post test counselling
NA Convenience, speed,
privacy, and anonymity
NA
Gaydos 2011
[24]
USA NA 5%–10% difficulties in
test performance and
test interpretation
NA 91% preferred
oral fluid versus
blood-based tests
Carballo-Dieguez
2012 (a) [16]
USA NA Errors in conduct: (1)
touch test pad; (2) swab
multiple times; (3)
eating/drinking just
before taking the test;
(4) almost drinking the
solution in the vial
87% for would likely
self-test if available
OTC and 80% would
likely use it to test
partners at home
NA
Pant Pai 2012 [29] Canada 78% for post-test at
community clinics, 53%
post-test on the phone, 31%
at pharmacies, 29% online
NA 98% convenience,
96% time efficient,
84% pain free
NA
OraSure 2012
(phase IIb) [13]
USA NA 1.82% error rate in population
of unknown status; 4.76%
error in HIV positive population
NA NA
Belza 2012 [21] Spain NA 1% invalid tests NA NA
Ng 2012 [28] Singapore 72.5% for pre-test counselling;
73.9 for post-test counselling
Errors due to conduct:
(1) use of collection pad
to swap external lips; (2)
touching the swab during
removal from packaging; (3)
spilling the test solutions; (4)
misinterpret negative or invalid
test results
Convenience, speed,
privacy, and
anonymity; kit
instructions easy to
understand
87.4% would but
an OTC rapid test
kit and 89%
wanted to
conduct HIV
testing in private
Chavula 2011 [17] Malawi Post-test counselling
considered essential
NA NA NA
Choko 2011 [33] Malawi 90% preferred pre-test; 70%
prefer in-person counselling
over telephone counselling
or information leaflets
Errors in conduct: (1) early
removal of kit from the
developer; (2) spilling the
developer fluid
NA NA
MacPherson 2011
[18]
Malawi NA NA NA NA
Test strategy: unsupervised
Kalibala 2011 [12] Kenya Telephone-based counselling NA NA
Katz 2012 [25] USA NA Convenience, speed,
privacy, and
anonymity
NA
OraSure 2012
(phase III) [13]
USA 88% sought post-test
counselling
Test system failures:
interpretational and operational
errors:
high-prevalence settings:
1.25%
(95% CI 0.95%–1.63%);
low-prevalence
settings: 0.37% (95%
CI 0.10%–0.93%); 96%
newly diagnosed HIV positive
subjects wanted
to seek linkages and
follow up;
97% would recommend
oral self tests to others,
79% would use for self
test
NA
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in the unsupervised strategy, one study from the US reported a
slightly lower sensitivity of 92.9% (95% CI 86.5–96.9) in a high-
prevalence setting (HIV prevalence.1%), compared to a sensi-
tivity of 100% (95% CI 99.7–100) in a low-prevalence setting
(HIV prevalence#1%) [13].
Agreement and Concordance
Agreement and concordance between the self-tester and HCP
could only be reported and computed for supervised testing
strategies. Six studies reported data on concordance of self-testing
results compared to test performed by HCPs [21,24,27–29,32].
The five studies using oral self tests noted a higher agreement for
oral self tests (95%–100% or k= 0.97) [21,24,28,29,32] in
comparison to finger-stick self tests (k value = 0.28) [27]. Further-
more, a time trend was observed across studies, with a lower
agreement reported in early studies (from 2001).
Feasibility
Ten studies evaluated the feasibility of self-testing strategies,
with various feasibility outcomes documented across studies.
Feasibility outcomes included test conduct, test interpretation,
post-test counselling, and treatment linkages.
In the unsupervised strategy, about 95% (n= 37/39) of urban
MSM in the US found the kits to be ‘‘very easy to use’’ and no test
errors were reported [25]. However, an implementation study
evaluating the same strategy in the US in general populations
reported on operator errors (interpretational and observational)
[13]. These failures varied from 0.37% (n= 4/1,093) in low-
prevalence settings to 1.25% (n= 56/4,465) in high-prevalence
settings. A Spanish study evaluating an unsupervised strategy
reported an overall interpretation error rate of 5.4% (n= 28/519)
[23], which included a 1.1% (n= 11/1,038) error in interpretation
of a positive result as negative.
Seven studies that evaluated supervised strategies documented
errors in test performance [13,16,21,24,28,32,33]. Errors docu-
mented in general population in urban Malawi requested
significantly more assistance from HCPs during self-testing with
oral tests; errors were noted as a result of early removal of kit from
the developer and spilling of the developer fluid [33]. Two studies
from Singapore and Spain with finger-stick tests reported a high
degree of errors, where 0.5% (n= 1/200) of participants obtained
invalid self-test results [28] and about 1% (n= 2/208) of the finger-
stick self-test results were found to be invalid [21]. In comparison,
test conduct and performance errors noted with oral tests were: (i)
collecting the oral mucosal sample, (ii) reading test instruction,
and, (iii) interpreting test results [24].
In the study that evaluated both strategies, a higher error rate
(4.76%, n= 24/504) was observed in test performance and
interpretation by populations who tested positive for HIV in a
supervised setting compared to unscreened or low-risk populations in
an unsupervised strategy (1.25%, n= 56/4,465) [13]. This difference
was attributed to the fact that, being already aware of their sero-
status, individuals testing positive for HIV that self-tested did not
care to read the instructions carefully and subsequently made more
errors than unscreened populations. Two studies from the US have
demonstrated that an improvement in self-test instructions for test
conduct and interpretation reduce the incidence of errors [27,32].
Data on post-test linkages were sparse. Linkage data were reported
in only one study from the US that has evaluated an unsupervised
strategy. It demonstrated that 96% (n= 102/106) of participants testing
positive for HIV stated they would seek post-test counselling [13].
Overall in both strategies, a pattern of errors in self-test conduct
was noted: (1) failing to place the oral test device in the developer
solution after swabbing [32], (2) removing the test kit from the
developer solution too early [33], (3) spilling the developer fluid
[13,28,33], and lastly (4) dipping the test device in the developer
solution before swabbing the gums [13,16]. Likewise, errors in self-
test interpretation were also reported: (1) difficulty in interpreting
the test result on the device [24,28] and (2) inability to read or
interpret faint or weakly positive test lines on the test device [13].
Motivators to Self-Test
Across all settings, both for the supervised and unsupervised self-
testing strategies, motivators to self-testing were: (a) convenience,
Table 4. Cont.
Test
Strategy Author Year
Study
Setting Counselling Preference
Feasibility, Linkages,
Errors
Motivation, Label
Comprehension Test Preference
Fuente 2012 [23] Spain NA 5.4% (95% CI 3.4–7.4)
misinterpretation of
self-test result picture;
6.6% with valid results
find instructions ‘‘somewhat’’
or ‘‘quite difficult’’ versus 20%
with invalid results
83.9% felt more
motivated after
taking the test to
self-test in future
Lee 2012 [26] USA NA NA High-label
comprehension among
intended user
populations 98.8%
(95% CI 97.4–99.6)
NA
Carballo-Dieguez
2012 (b) [22]
USA NA NA Availability of OTC
would increase testing
frequency
‘‘High
acceptability’’
among ethnic
minority
participants and
ethnic minority
sex partners
Helm 2012 [20] Netherlands NA NA NA NA
NA, not available; WTP, willingness to pay.
doi:10.1371/journal.pmed.1001414.t004
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(b) speed and time to test result, (c) privacy, (d) a sense of
empowerment, and, lastly, (e) a control of one’s health choices
[13,16,19,22,25–30].
In a supervised strategy evaluated in an educated population in
Canada, convenience (99%, n= 99/100), time efficiency (97%,
n= 97/100), and the pain-free procedure (84%, n= 84/100) were
identified as motivators to self-testing [29]. In supervised strategies,
in Malawi, participants preferred the distribution of test kits by one
person (neighbourhood counsellor or trained person) and coun-
selling by another person to maintain anonymity of self-testing
[17]. Similarly, in a study with HIV clinic attendees in the US,
92% (n= 67/73) of participants cited provision of instant results,
and 45% (n= 33/73) mentioned anonymity, confidentiality, and
privacy as factors favoring self tests over conventional tests [30].
Likewise, in another supervised strategy evaluated in non-
monogamous urban MSM in the US, 87% (n= 50/57) were likely
to buy self tests, and 80% (n= 46/57) wanted to use it to test
partners at home [16].
In unsupervised strategies, 7% (n= 19/288) of participants with
valid results and 20% (n= 5/25) with invalid results found the test
instructions ‘‘somewhat’’ or ‘‘quite’’ difficult to read, while most
participants did not document difficulties following the test kit
instructions [23]. High comprehension of instructions for use was
also observed among intended user population in a study based in
the US [26], and a study among urban non-monogamous MSM in
the US documented that OTC availability of self tests would
increase the frequency of testing in this population [22]. In another
study evaluating an unsupervised testing strategy, a high percent-
age (79%, absolute number not reported) of HIV negative subjects
expressed a desire to use a self test at home if available OTC, and
97% (absolute number not reported) of subjects newly diagnosed
with HIV expressed a desire to recommend this OTC test to a
friend [13].
Preference
Three preference outcomes were documented: (a) preference for
test and strategies, (b) cost preference and willingness to pay, and
(c) preference for counselling.
Preference for tests and strategies. This outcome was
variously documented. It included: (a) preference for oral versus
finger-stick self test, (b) preference for self-testing strategy over
conventional testing strategy, and (c) preference for self-testing of
partners.
A majority (n= 14/21, 67%) of studies evaluated oral fluid tests
for both strategies, and preference was attributed to the tests’ non-
invasiveness, convenience, and ease of specimen collection.
Furthermore, in studies from the US where participants were
offered a choice between oral and finger-stick, 91% (n= 433/478)
chose oral fluid tests over blood-based tests (9%, n= 45/478) in
one study [24], while in the other, 61% (n= 146/240) of
participants preferred the oral test over the finger-stick test [32].
In a Canadian study with students, 81% (n= 81/100) preferred self
tests over conventional lab tests, and 74% (n= 74/100) expressed a
desire to buy them OTC [29].
For unsupervised strategies, in another US study in general
populations and individuals of known positive HIV status, about
79% (absolute number not reported) preferred to self-test using
oral over conventional tests, and 97% (absolute number not
reported) wished to use oral tests to test their partners [13]. In
Spain, 84% (n= 436/519) of the participants undergoing unsu-
pervised testing felt more motivated after taking the test to self-test
in the future [23]. Finally, a study among urban non-monogamous
Figure 2. Self-testing strategies: a classification.
doi:10.1371/journal.pmed.1001414.g002
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MSM in the US documented ‘‘high acceptability’’ of the
unsupervised self-testing strategy among ethnic minority partici-
pants and their sex partners [22].
Cost preference and willingness to pay. Cost preference
for self tests and willingness to pay if sold OTC were documented
for both supervised and unsupervised strategies, and varied across
populations, settings and strategies [23,25,27,29–31,32].
In supervised strategies, in Canada, 32% (n= 32/100) of university
students were willing to pay up to US$10 and 41% (n= 41/100) up to
US$20 [29], while in Singapore, 88% (n= 370/420) were willing to
pay between US$7 and US$13, and 28% (n= 118/420) more than
US$15 [27]. In a study in the US, 70% (n= 168/240) were willing to
pay up to US$15, and 40% (n= 96/240) would be willing to pay
US$20 for it [32]. In another study in the US, at-risk participants
from homeless shelters wanted free self tests [30].
In unsupervised strategies evaluated in an urban MSM
population, 45% (n= 49/108) were willing to pay less than
US$20, 25% (n= 27/108) between 20 and US$40, 17% (n= 18/
108) more than US$40 and 13% (n= 14/108) wanted it free [25].
Additionally, in Kenya, HCPs were unwilling to pay and wanted
the government to provide it for free, as HIV was perceived to be
an occupational risk [12]. A study in Spain evaluating an
unsupervised strategy in attendees at a rapid HIV testing site
documented 18% (n= 56/313) willingness to pay more than
US$38, 22% (n= 69/313) between US$25 and US$28 and 5%
(n= 16/313) wanting it for free [23].
Preference for counselling. Preferred mode and medium of
counselling varied by strategies, as well as by educational and socio-
economic status of the self-testers, which dictated their access to
resources such as mobile phones, Internet, and pharmacies. In both
supervised and unsupervised strategies, participants agreed that both
pre- and post-counselling were essential components that needed to
be integrated in the testing process [12,13,17,19,27–30,33].
Regarding preference for counselling in supervised strategy, in
two studies from Singapore, 79% and 74% (n= 275/350and
n= 735/994) of participants felt that confidential post-test coun-
selling was essential [27,28]. In India, participants from the
general population brought to community internet centers
preferred computer-based counselling [19], while in San Fran-
cisco, homeless men preferred face-to-face counselling [30]. In a
study from Malawi, participants indicated post-test counselling was
essential, but agreed that it did not have to be immediately
available following self-testing for test negative participants [17].
Regarding mode of counselling, in a study conducted in student
populations in Montreal, students’ preferred counselling options
that were through community clinics (78%, n= 78/100), by phone
(53%, n= 53/100), at pharmacies (31%, n= 31/100), and by
Internet (29%, n= 29/100) [29]. In Malawi, most participants
(including repeat testers) preferred face-to-face counselling over
phone-based counselling [33].
Data for preference for and mode of counselling for the
unsupervised strategy was limited. In the US, a high preference
(88%, n = 93/106) was noted for post-test counselling, and 96%
(n = 102/106) of subjects newly diagnosed with HIV indicated
they would follow up for positive self-test results with a doctor
or a clinic [13]. Among the subjects who tested positive for
HIV who received post-test counselling, 69% (absolute number
not reported) were calm upon learning their status, while 31%
(absolute number not reported) indicated some level of anxiety;
however, no intervention (suicide helpline) was required for
any of these subjects [13]. In a study from Kenya, telephone-
based counselling from a call-center was deemed useful by
HCPs [12].
Qualitative Data
Qualitative data were sparse and reported in five studies [12,16–
19]. A mixed methods study in Kenyan HCPs incorporated
qualitative data to assess feasibility, acceptability, and barriers and
the influence of self-testing on couples testing choices [12].
Another US-based study questioned MSM on the use of self tests
to screen potential sexual partners [16]. A study in urban India
surveyed general population at community internet centers [19],
while two other US-based studies elucidated social and structural
barriers (challenges, concerns, and barriers) [17,18]; these issues
are discussed in detail below.
Challenges
Challenges in self-testing with a partner were discussed for both
strategies: unsupervised strategy among HCPs in Kenya and
supervised strategy in high-risk MSM in the US [12,16]. Kenyan
HCPs noted that the key challenge was avoiding the potential
misuse of self tests, including non consensual testing [12]. In
another study that evaluated a supervised strategy with non-
monogamous MSM, refusal of new partners to self-test was flagged
as a possible positive HIV status that would deter them from
having sex or encourage them to use condoms [16]. Participants
also indicated that the self test would ‘‘kill the mood’’ if used right
before sex and being under the influence of drugs and/or alcohol
could also dissuade testing altogether [16].
Concerns
Concerns regarding both strategies included accuracy, stigma,
misuse, and potential abuse of self tests. A lack of trust in the
accuracy of self-test results was reported in two studies [29,30],
while in one US-based study, 94% (n = 407/433) of participants
trusted their oral fluid results more than their finger-stick results
(87%, n = 39/45) [24]. In supervised self-testing strategies, where
part of the self-test distribution or assistance was offered by
counsellors or provided at visible testing centers, perceived stigma
as a barrier was reported by participants in two studies [18,19].
HCPs in Kenya described potential misuse of self tests including
non-consensual testing of partners and children/infants, mali-
ciously infecting others if found positive, and unauthorized selling
of the test kit [12].
Barriers
Study participants for both strategies in both settings perceived
barriers. In the supervised testing strategy, stigma and discrimi-
nation, and sequelae surrounding a diagnosis of HIV was high in
Malawi, with 22% (n= 47/216) of participants fearing verbal
abuse, 14% (n= 29/216) thinking they would be excluded by
friends, and 10% (n= 11/110) of women and 11.3% (n= 12/106)
of men fearing that their partner would leave them in case they
tested positive for HIV [18]. In an unsupervised strategy evaluated
in Kenya, a fear of visibility discouraged HCPs because they did
not want to be seen carrying the self-test kits [12].
Quality of Studies
Quality of studies varied. A lack of standardization in reporting
and documentation of outcomes was observed. Qualitative data
were sparse and evaluation of quality limited by incomplete
reporting of data in abstracts. Combined reporting of quantitative
and qualitative findings along with insufficient reporting of the
qualitative methods and data collection tools (e.g., content of
interview guide) may have masked potentially useful qualitative
evidence. In a US study, the rationale for employment of different
methodologies was clearly explained, and care was taken to reduce
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bias [16]. However, lack of clear presentation of themes in the
results limited our understanding of collected data.
Discussion
We identified 21 studies that assessed supervised or unsuper-
vised HIV self-testing strategies. The majority of the evidence from
included studies was for supervised strategies from high-resource
settings, although seven recent studies reported on an unsuper-
vised strategy [12,13,20,22,23,25,26]. Included studies recorded a
high score for acceptability (range: 74%–96%), preference over
facility-based testing (range: 61%–91%), and partner self-testing
(range: 80%–97%). Sensitivity and specificity for both unsuper-
vised and supervised self-test strategies was high, but a lower
sensitivity was reported for unsupervised (range: 92.9%–100%;
one study) versus supervised (range: 97.4%–97.9%; three studies)
strategies. Only one of the included studies reported on linkage to
counselling and care where 96% (n= 102/106) of individuals who
tested positive for HIV stated they would seek post-test counsel-
ling.
While the evidence of high acceptability for supervised strategies
is clear, it is not so for unsupervised strategies, especially in
resource constrained settings. Only one study evaluated it, and the
study focused on acceptability in a health literate population
(HCPs) [12]. In terms of interpretation, self-testing has to be
viewed as a process that requires a higher level of motivation and
pro-activity compared to facility-based conventional testing. It
involves a certain level of independence and assumes a basic level
of literacy (typically grade 6 or high school) to ensure confidence in
the self-test conduct and interpretation and enough personal
involvement to seek post-test counselling and linkage to care and
treatment. In addition to motivation, the conduct of a self test and
its interpretation are key to its successful implementation.
Additionally, demystifying the process of self-testing on television
and social media will improve passive absorption, help de-
stigmatize the HIV testing process, and promote the visibility of
a self-testing strategy while providing information on HIV.
Therefore, more research on exploring the best strategy (i.e.,
supervised versus unsupervised strategies) for different high- and
low-risk populations in resource-constrained settings is clearly
needed.
Evidence for preference for self tests was evident for both
supervised and unsupervised strategies, while mode and medium
of preferences for counselling varied across settings, populations,
and strategies. In terms of interpretation, qualitative research will
help understand and tailor the preferred counselling option to
high- and low-risk populations in diverse settings. Counselling
strategies must be tailored to the literacy levels, lifestyle needs, and
preferences, especially for populations living in resource con-
strained settings.
For cost preferences, low-income populations in both high- and
low-resource settings tended to prefer free self tests whereas higher
income groups in both settings were willing to pay typically up to
US$20. This finding implies that the price of a self-test kit will be
an important factor in determining the uptake of self tests.
Qualitative research will help guide the ranges of cost preference.
This is crucial to policy initiatives for both strategies in both
settings.
Regarding findings on accuracy, while a consistently high
specificity was noted for both strategies across all settings, a wide
variability in sensitivity estimates was observed. Lower sensitivity
was more prominent in studies that used the unsupervised self-
testing strategy. Interestingly, lower estimates of sensitivity were
also reported from high-prevalence settings, conducted by at-risk
testers that were experienced with testing (including individuals
who knew their sero-status) but generated more errors with the self
test by not complying with instructions compared to individuals
who did not know their sero-status. In contrast, naı¨ve self-testers in
low-risk settings seemed to follow instructions diligently resulting in
high estimates of sensitivity. Although this process of passive
absorption and priming to self-test instructions was present in
supervised strategies in high-income settings where it resulted in
fewer errors and highly accurate results, it was notably absent or
weakly implemented in the unsupervised strategy. This finding
highlights the importance of improving clarity of instructions to
self-test. In terms of generalizability, adapting these instructions to
contexts and populations with use of various media (pictorial and
textual instructions, web, social media, or smartphone-based
content in a user friendly format) and tailoring to languages and
levels of literacy especially for low-resource settings will be
essential.
In terms of feasibility, none of the existing literature addressed
issues related to seeking linkage to care (obtaining a CD4 count or
having visited a clinic for ART initiation) and evidence from only
one study reported that 96% (n= 102/106) of individuals who
tested positive for HIV stated they would seek post-test counsel-
ling. Linkages could be better documented in the next phase of
controlled studies.
Furthermore, in planning roll out of self-testing strategies,
clarification of some concepts and limitations of the self tests to
potential self-testers is necessary. These include presence of faint
positive lines and their interpretation as a positive test result, and
the limitation of antibody-based self tests to detect an HIV
infection only after 90 d. With either strategy, occurrence of false
negatives or indeterminate test outcomes cannot be eliminated
with antibody-based oral or finger-stick self tests so repeat testing
at 3-mo intervals should always be encouraged. At any time,
calling or meeting a counsellor for clarification of test results must
be emphasized.
For poor and less literate populations who cannot afford self
tests or cannot comprehend the process of testing, the supervised
self-testing strategy may remain the best option. But this option
requires a careful controlled evaluation in many sub-Saharan and
Asian settings. Engagement of providers and stakeholders is a
necessary first step before implementation of a self-testing strategy
because treatment and staging must be available for newly
diagnosed individuals with HIV. Efforts must be made to avoid
loss to follow up.
In under regulated and under funded health systems, it will be
important to regulate the quality of self-test kits along with the
process of self-testing. In contrast, in well-managed health systems
in high-income countries (e.g., US, Canada, UK, Australia,
Singapore, Japan) and populations with high socio-economic
status in emerging economies and middle-income countries
(China, South Africa, Russia, India, Brazil, Colombia), affordable
OTC self tests sold at pharmacies or online should work well with
linkages operationalized by counsellors via different mediums,
such as over the phone, the Internet, or face-to-face at a clinic.
Evidence of extreme adverse effects, for example suicide, and
the potential for abuse of self tests was consistently absent.
However, as such evidence is collected in well-controlled studies,
such data from a real world context will be hard to document.
Anecdotal evidence suggests that unregulated rapid tests are
available in markets of African and Asian countries and that such
abuse will happen regardless of the introduction of self tests.
Nevertheless, safeguards introduced by public health systems could
help minimize the problem. To reach preliminary self-testers, a
24/7 toll free number to reach counsellors in time, and the offer of
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an option of face-to-face counselling could help obviate the
occurrence.
In terms of new research, controlled clinical trials in different
populations and settings with exploration of tailored and novel
linkage modalities are urgently needed. This will generate the best
evidence on offering an optimal and tailored strategy suited to the
needs of different populations and settings. The impact of self-
testing on detecting new cases of HIV in the community and
changes in sexual behaviour of self-testers post-testing are yet to be
assessed. Because data on prior HIV testing behaviour for
unsupervised strategies were undocumented, new knowledge on
whether self-testing reached new testers is unclear and therefore
needed. Data on the impact of self-testing in increasing
community engagement in screening, and on long term HIV
outcomes remain limited. These data can be documented through
community-based cluster RCTs or implementation research.
However, it is hard to conduct such trials in communities when
self tests are not approved for use in many countries and especially
in health systems where linkage to counselling is not in place.
Lastly, formative research that further explores individual
motivations in using self tests, their fears, perceptions, and
concerns, is needed. It will assist in tailoring self-testing to the
needs and preferences of individuals and communities.
In sum, self-testing offers an alternative for individuals who
desire privacy and confidentiality to find out their sero-status, as
well as for under-resourced health care systems and settings where
stigma and discrimination may prevail. It offers the potential to
bring more people to self-screen and proactively seek linkage to
care and prevention, but its potential in optimizing linkages
remains unproven. However, if optimized, self-testing could
facilitate and motivate individuals who preliminarily tested positive
for HIV to seek care and counselling. Furthermore, care seeking
should not be left to the motivated self-tester, but facilitated
through various means, including technological innovations. But
in any such system, if any component of self-testing, linked
counselling and initiation of care are poorly managed, then the
self-testing strategy could cause more harm than good. At all times
therefore, linking positive self-test results within an 8–24-h window
period to post-test counselling followed up by CD4 count and
ART initiation should continue to be emphasized.
Strengths and Limitations
Approximately 70% of the included studies were cross-sectional
in design. The majority of the data were primarily derived from
implementation studies and from high-income settings (89%), only
one of which was an RCT. Few studies were conducted in
resource constrained countries, none of which were RCTs. Lack of
data from resource constrained settings limited our comparisons of
supervised versus unsupervised test strategies (one unsupervised
study of HCPs in Kenya [12] and one supervised study of an
urban population in Malawi [33]). Data on linkage to care was
sparse with only one unsupervised self-testing study reporting
linkage to care as an outcome. Selection and volunteer bias (self-
selection of participants) within included studies cannot be ruled
out. Publication and reporting bias are also likely. Errors in test
interpretation were recorded in three studies. With these errors, a
potential misclassification of false negative test results and
misinterpretation of faint positive lines is probable; hence
information bias (misclassification of test results) is also likely.
The quality of reporting in included studies was generally poor.
STARD and QUADAS checklists could not be used to assess
quality because they are tailored for diagnostic accuracy, which
was not the primary outcome in most studies. The use of
observational study designs, data from pilot studies, with
incomplete reporting of data items and lack of compliance with
STROBE reporting criteria, were typical problems encountered in
our quality assessment of the studies. A general lack of
standardized reporting of outcomes beyond accuracy (patient
centered outcome or implementation research outcomes) in the
field of POC diagnostics has been noted [34]. It is therefore not
surprising that these outcomes were heterogeneously and incom-
pletely reported across many studies. The wide range of sources
searched, the lack of language restrictions, and the evaluation of
study quality are strengths of this review.
Conclusion
Privacy, anonymity, time-savings, and convenience facilitated a
high acceptability and preference for both supervised and
unsupervised self-testing strategies across diverse global settings.
Included studies demonstrated that it was feasible to implement
both supervised and unsupervised oral fluid-based self-testing
strategies, despite variable accuracy estimates obtained by self-
testers. However data on linkages to care were only reported by a
single study of unsupervised self-testing. Self-testing can be an
alternative option to facility-based testing for individuals who
desire more privacy. However, controlled trials wherever possible,
and implementation studies that document linkage to care, are
warranted to confirm findings from observational studies.
Although self-testing offers the potential to increase the number
of individuals to self-screen for HIV and therefore deliver more
people to care, systems that can maintain confidentiality and
operationalize linkage to care within a reasonable time frame are
pertinent to its success. More data from diverse settings are needed
to inform global scale-up and policy recommendations for HIV
self tests.
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Editors’ Summary
Background. About 34 million people (most living in
resource-limited countries) are currently infected with HIV,
the virus that causes AIDS, and about 2.5 million people
become infected with HIV every year. HIV is usually
transmitted through unprotected sex with an infected
partner. HIV infection is usually diagnosed by looking for
antibodies to HIV in blood or saliva. Early during infection,
the immune system responds to HIV by beginning to make
antibodies that recognize the virus and target it for
destruction. ‘‘Seroconversion’’—the presence of detectable
amounts of antibody in the blood or saliva—usually takes 6–
12 weeks. Rapid antibody-based tests, which do not require
laboratory facilities, can provide a preliminary result about an
individual’s HIV status from a simple oral swab or finger stick
sample within 20 minutes. However preliminary rapid
positive results have to be confirmed in a laboratory, which
may take a few days or weeks. If positive, HIV infection can
be controlled but not cured by taking a daily cocktail of
powerful antiretroviral drugs throughout life.
Why Was This Study Done? To reduce the spread of HIV,
it is essential that HIV-positive individuals get tested, change
behaviors avoid transmitting the virus to other people by, for
example, always using a condom during sex, and if positive
get on to treatment that is available worldwide. Treatment
also reduces transmission of virus to the partner and controls
the virus in the community. However, only half the people
currently living with HIV know their HIV status, a state of
affairs that increases the possibility of further HIV transmis-
sion to their partners and children. HIV positive individuals
are diagnosed late with advanced HIV infection that costs
health care services. Although health care facility-based HIV
testing has been available for decades, people worry about
stigma, visibility, and social discrimination. They also dislike
the lack of privacy and do not like having to wait for their
test results. Self-testing (i.e., self-test conduct and interpre-
tation) might alleviate some of these barriers to testing by
allowing individuals to determine their HIV status in the
privacy of their home and could, therefore, increase the
number of individuals aware of their HIV status. This could
possibly reduce transmission and, through seeking linkages
to care, bring HIV under control in communities. In some
communities and countries, stigma of HIV prevents people
from taking action about their HIV status. Indeed, an oral
(saliva-based) HIV self-test kit is now available in the US. But
how acceptable, feasible, and accurate is self-testing by lay
people, and will people who find themselves self-test
positive seek counseling and treatment? In this systematic
review (a study that uses pre-defined criteria to identify all
the research on a given topic), the researchers examine these
issues by analyzing data from studies that have evaluated
supervised self-testing (self-testing and counseling aided by
a health-care professional) and unsupervised self-testing
(self-testing performed without any help but with counseling
available by phone or internet).
What Did the Researchers Do and Find? The researchers
identified 21 eligible studies, two-thirds of which evaluated
oral self-testing and a third of which evaluated blood-based
self-testing. Seven studies evaluated an unsupervised self-
testing strategy and 14 evaluated a supervised strategy.
Most of the data (89%) came from studies undertaken in
high-income settings. The study populations varied from
those at high risk of HIV infection to low-risk general
populations. Across the studies, acceptability (defined as the
number of people who actually self-tested divided by the
number who consented to self-test) ranged from 74% to
96%. With both strategies, the specificity of self-testing (the
chance of an HIV-negative person receiving a negative test
result is true negative) was high but the sensitivity of self-
testing (the chance of an HIV-positive person receiving a
positive test result is indeed a true positive) was higher for
supervised than for unsupervised testing. The researchers
also found evidence that people preferred self-testing to
facility-based testing and oral self-testing to blood-based self
testing and, in one study, 96% of participants who self-tested
positive sought post-testing counseling.
What Do These Findings Mean? These findings provide
new but limited information about the feasibility, accept-
ability, and accuracy of HIV self-testing. They suggest that it
is feasible to implement both supervised and unsupervised
self-testing, that both strategies are preferred to facility-
based testing, but that the accuracy of self-testing is variable.
However, most of the evidence considered by the research-
ers came from high-income countries and from observation-
al studies of varying quality, and data on whether people
self-testing positive sought post-testing counseling (linkage
to care) were only available from one evaluation of
unsupervised self-testing in the US. Consequently, although
these findings suggest that self-testing could engage
individuals in finding our their HIV status and thereby help
modify behavior thus, reduce HIV transmission in the
community, by increasing the proportion of people living
with HIV who know their HIV status. The researchers
suggested that more data from diverse settings and
preferably from controlled randomized trials must be
collected before any initiatives for global scale-up of self-
testing for HIV infection are implemented.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001414.
N Information is available from the US National Institute of
Allergy and Infectious Diseases on HIV infection and AIDS
N NAM/aidsmap provides basic information about HIV/AIDS
and summaries of recent research findings on HIV care and
treatment
N Information is available from Avert, an international AIDS
charity on many aspects of HIV/AIDS, including informa-
tion on HIV testing, and on HIV transmission and testing (in
English and Spanish)
N The UK National Health Service Choices website provides
information about all aspects of HIV and AIDS; a ‘‘behind
the headlines’’ article provides details about the 2012 US
approval for an over-the-counter HIV home-use test
N The 2012 World AIDS Day Report provides information
about the percentage of people living with HIV who are
aware of their HIV status in various African countries, as
well as up-to-date information about the AIDS epidemic
N Patient stories about living with HIV/AIDS are available
through Avert; the nonprofit website Healthtalkonline also
provides personal stories about living with HIV, including
stories about getting a diagnosis
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